A detailed history of Klp Kapitalforvaltning As transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 5,900 shares of YMAB stock, worth $36,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,900
Holding current value
$36,285
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$7.76 - $15.69 $45,784 - $92,571
5,900 New
5,900 $46,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $269M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.